Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 227

Horizn Studios bags series A capital

Vorwek-backed travel accessory manufacturer Horizn Studios has raised several million dollars in its series A round to expand internationally, beginning with the UK.

Dec 16, 2016

Inke and FunPlus make Next move

Next Entertainment, a live video streaming platform curated by livestreaming company Inke and game developer FunPlus, has raised $25m in a series A round.

Dec 16, 2016

BillFront rings up $35m

Fintech company BillFront has raised a combination of series A equity and debt from strategic investors NIBC Bank and 4Finance as well as existing shareholder Finleap.

Dec 15, 2016

Signal filters $7.4m for series A round

AI-powered media analysis startup Signal Media has raised new funding from investors including Hearst Media and RELX, after securing seed capital last year.

Dec 15, 2016

Lola latches on to $7m

The organic tampon provider, which has raised $10m in 2016, secured funding from investors including the AOL-backed BBG Ventures.

Dec 14, 2016

ApoGen applies itself to $7m series A

AbbVie, Eli Lilly, WuXi PharmaTech, Johnson & Johnson and Alexandria Real Estate Equities are among the investors in the genomic cancer treatment developer.

Dec 14, 2016

Mojio revs up series A to $15m

Amazon provided a $7m extension to the connected car technology developer's series A round, which already contained Deutsche Telekom.

Dec 13, 2016

BlueRock Therapeutics generates $225m series A

Bayer Lifescience Center joined Versant Ventures to launch BlueRock, which will develop stem cell treatments for cardiovascular diseases and neurodegenerative disorders.

Dec 13, 2016

Vesper sounds out corporates for $15m series A

Advanced microphone technology developer Vesper's investors include Amazon's Alexa Fund, AAC Technologies, Mirae Nano Tech and XinGang Electronics.

Dec 12, 2016
© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here